IL148738A0 - Quinoline and naphthyridine carboxylic acid antibacterials - Google Patents
Quinoline and naphthyridine carboxylic acid antibacterialsInfo
- Publication number
- IL148738A0 IL148738A0 IL14873800A IL14873800A IL148738A0 IL 148738 A0 IL148738 A0 IL 148738A0 IL 14873800 A IL14873800 A IL 14873800A IL 14873800 A IL14873800 A IL 14873800A IL 148738 A0 IL148738 A0 IL 148738A0
- Authority
- IL
- Israel
- Prior art keywords
- quinoline
- carboxylic acid
- naphthyridine carboxylic
- antibacterials
- acid antibacterials
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43529799A | 1999-11-05 | 1999-11-05 | |
| US70533200A | 2000-11-03 | 2000-11-03 | |
| PCT/US2000/030551 WO2001032655A2 (en) | 1999-11-05 | 2000-11-06 | Quinoline and naphthyridine carboxylic acid antibacterials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL148738A0 true IL148738A0 (en) | 2002-09-12 |
Family
ID=27030507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14873800A IL148738A0 (en) | 1999-11-05 | 2000-11-06 | Quinoline and naphthyridine carboxylic acid antibacterials |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1226146A2 (en) |
| JP (1) | JP2003524633A (en) |
| AR (1) | AR030537A1 (en) |
| AU (1) | AU1468901A (en) |
| BG (1) | BG106679A (en) |
| BR (1) | BR0010728A (en) |
| CZ (1) | CZ20021531A3 (en) |
| HK (1) | HK1047287A1 (en) |
| IL (1) | IL148738A0 (en) |
| MX (1) | MXPA02004474A (en) |
| NO (1) | NO20022156L (en) |
| WO (1) | WO2001032655A2 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1313708A1 (en) * | 2000-08-29 | 2003-05-28 | Chiron Corporation | Quinoline antibacterial compounds and methods of use thereof |
| CN100350036C (en) | 2001-04-27 | 2007-11-21 | 宝洁公司 | Apparatus and method for controlling biofilms |
| US8163769B2 (en) | 2002-03-12 | 2012-04-24 | Abbott Laboratories | Antibacterial compounds |
| EP1631570A1 (en) * | 2003-03-12 | 2006-03-08 | Abbott Laboratories | Naphthyridine derivatives as antibacterial agents |
| EP1829869A1 (en) * | 2006-03-02 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| US20080139574A1 (en) | 2006-11-30 | 2008-06-12 | Cadila Healthcare Limited | Novel quinoline derivatives |
| TWI498115B (en) * | 2007-12-27 | 2015-09-01 | Daiichi Sankyo Co Ltd | Imidazole carbonyl compounds |
| NZ600008A (en) | 2009-12-04 | 2014-10-31 | Sunovion Pharmaceuticals Inc | Multicyclic compounds and methods of use thereof |
| MX2019000980A (en) | 2016-07-29 | 2019-07-04 | Sunovion Pharmaceuticals Inc | Compounds and compositions and uses thereof. |
| KR20190065246A (en) | 2016-07-29 | 2019-06-11 | 선오비온 파마슈티컬스 인코포레이티드 | Compounds and compositions and uses thereof |
| JP7146782B2 (en) | 2017-02-16 | 2022-10-04 | サノビオン ファーマシューティカルズ インク | Methods of treating schizophrenia |
| WO2019028165A1 (en) | 2017-08-02 | 2019-02-07 | Sunovion Pharmaceuticals Inc. | Isochroman compounds and uses thereof |
| EA202091945A1 (en) | 2018-02-16 | 2021-01-18 | Суновион Фармасьютикалз Инк. | SALTS, CRYSTALLINE FORMS AND METHODS OF THEIR PRODUCTION |
| MX2021010880A (en) | 2019-03-14 | 2022-01-18 | Sunovion Pharmaceuticals Inc | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof. |
| EP4135690A1 (en) | 2020-04-14 | 2023-02-22 | Sunovion Pharmaceuticals Inc. | (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4665079A (en) * | 1984-02-17 | 1987-05-12 | Warner-Lambert Company | Antibacterial agents |
-
2000
- 2000-11-03 AR ARP000105819A patent/AR030537A1/en unknown
- 2000-11-06 AU AU14689/01A patent/AU1468901A/en not_active Abandoned
- 2000-11-06 JP JP2001535357A patent/JP2003524633A/en not_active Withdrawn
- 2000-11-06 IL IL14873800A patent/IL148738A0/en unknown
- 2000-11-06 WO PCT/US2000/030551 patent/WO2001032655A2/en not_active Application Discontinuation
- 2000-11-06 CZ CZ20021531A patent/CZ20021531A3/en unknown
- 2000-11-06 EP EP00976992A patent/EP1226146A2/en not_active Withdrawn
- 2000-11-06 BR BR0010728-0A patent/BR0010728A/en not_active Application Discontinuation
- 2000-11-06 MX MXPA02004474A patent/MXPA02004474A/en unknown
-
2002
- 2002-05-06 NO NO20022156A patent/NO20022156L/en not_active Application Discontinuation
- 2002-05-09 BG BG106679A patent/BG106679A/en unknown
- 2002-12-13 HK HK02109077.5A patent/HK1047287A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0010728A (en) | 2004-02-17 |
| HK1047287A1 (en) | 2003-02-14 |
| WO2001032655A2 (en) | 2001-05-10 |
| CZ20021531A3 (en) | 2002-09-11 |
| JP2003524633A (en) | 2003-08-19 |
| WO2001032655A3 (en) | 2002-01-24 |
| AR030537A1 (en) | 2003-08-27 |
| BG106679A (en) | 2003-01-31 |
| MXPA02004474A (en) | 2002-11-07 |
| AU1468901A (en) | 2001-05-14 |
| NO20022156L (en) | 2002-07-04 |
| EP1226146A2 (en) | 2002-07-31 |
| NO20022156D0 (en) | 2002-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1043124A1 (en) | Salt of naphthyridine carboxylic acid derivative. | |
| IL193071A0 (en) | Cyclopropyl carboxylic acid esters and derivatives | |
| EP1216980A4 (en) | Carboxylic acid derivatives and drugs containing the same | |
| HK1039939A1 (en) | Alpha-substituted carboxylic acid derivatives | |
| SG93823A1 (en) | Aryl-acrylic acid esters | |
| ZA982335B (en) | Salt of naphthyridine carboxylic acid derivative. | |
| IL148738A0 (en) | Quinoline and naphthyridine carboxylic acid antibacterials | |
| AU3312100A (en) | Hydroxamic and carboxylic acid derivatives | |
| EP1219662A4 (en) | Polyamic acid ester | |
| ZA9810298B (en) | Isothiazole carboxylic acid derivatives | |
| AU7940598A (en) | Quinolone carboxylic acid derivatives | |
| ZA973098B (en) | Novel carboxylic acid derivatives their preparation and use | |
| ZA973096B (en) | Novel carboxylic acid derivatives their preparation and use | |
| AU697025B2 (en) | Quinoline carboxylic acid | |
| HUT75640A (en) | Novel quinolone carboxylic acid derivatives | |
| HU9904659D0 (en) | Aryl carboxylic acid and tetrazole derivatives | |
| PL335601A1 (en) | Derivatives of 2-substituted benzoylcycloalkyl carboxylic acid | |
| ZA200202187B (en) | Quinoline and naphthyridine carboxylic acid antibacterials. | |
| HUP9902548A3 (en) | Process for preparing quinoline and naphthyridone carboxylic acids | |
| PL349394A1 (en) | Crystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s- 2,8- diazabicyclo- [4.3.0] nonan-8-yl) -6-fluoro -1,4-dihydro -4-oxo -3-quinoline carboxylic acid | |
| GB9911071D0 (en) | Hydroxamic and carboxylic acid derivatives | |
| PL347799A1 (en) | Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid | |
| GB9907082D0 (en) | The preparation of carboxylic acid derivatives | |
| GB9911075D0 (en) | HYdroxamic and carboxylic acid derivatives | |
| IL148669A0 (en) | 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof |